P514: V-FAST MASTER TRIAL: PRELIMINARY RESULTS OF TREATMENT WITH CPX-351 PLUS MIDOSTAURIN IN ADULTS WITH NEWLY DIAGNOSED FLT3-MUTATED ACUTE MYELOID LEUKEMIA

• J. McCloskey,
• V. Pullarkat,
• G. Mannis,
• T. L. Lin,
• S. A. Strickland,
• A. T. Fathi,
• H. P. Erba,
• S. Faderl,
• D. Chakravarthy,
• Y. Lutska,
• V. Chandrasekaran,
• R. S. Cheung,
• M. Levis

Affiliations

J. McCloskey

1 John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ

V. Pullarkat

2 City of Hope Comprehensive Cancer Center, Duarte, CA

G. Mannis

3 Stanford University Medical Center, Palo Alto, CA

T. L. Lin

4 University of Kansas Medical Center, Kansas City, KS

S. A. Strickland

5 Vanderbilt-Ingram Cancer Center, Nashville, TN

A. T. Fathi

6 Massachusetts General Hospital Cancer Center/Harvard Medical School, Boston, MA

H. P. Erba

7 Duke University School of Medicine, Durham, NC

S. Faderl

8 Jazz Pharmaceuticals, Palo Alto, CA

D. Chakravarthy

8 Jazz Pharmaceuticals, Palo Alto, CA

Y. Lutska

9 Jazz Pharmaceuticals, Philadelphia, PA

V. Chandrasekaran

9 Jazz Pharmaceuticals, Philadelphia, PA

R. S. Cheung

8 Jazz Pharmaceuticals, Palo Alto, CA

M. Levis

10 Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, United States of America